What is it about?

In this investigation, we show for the first time that a high fat, low carbohydrate ketogenic diet promotes tumor growth in an animal model of spontaneously occurring renal cancer. The report combines some unique attitudes. We applied a modification of a commercially used high fat, ketogenic diet which allowed us to continue its usage for a prolonged time (8 months; before now, four month was the longest period of animal feeding by a ketogenic diet). Furthermore, we performed an analysis of particular proteins such as p53, ERK1/2 or OGG1 which were not previously evaluated in the context of a ketogenic diet. Likewise, we performed measurements of the metabolites (metabolomic profiling), which allowed us to gain a clear understanding of the proposed mechanisms. Finally, this paper answers several important questions about the ketogenic diet action and concludes that this may compromise its anticancer/pro-tumorigenic abilities.

Featured Image

Why is it important?

Our results shed new light on many fields of nutrition and cancer research connected with the use of ketogenic diet as a form of therapy, because the diet is frequently considered as an anticancer agent. As a potential metabolic therapy it is often recalled in the context of cancer metabolism, a common subject of many current discussions.

Perspectives

By exploiting a rat model of tuberous sclerosis where the ketogenic diet is used as antiepileptic cure, we demonstrate the disadvantages of this therapy, giving implications for clinical practice.

Mr Arkadiusz Damian Liśkiewicz

Read the Original

This page is a summary of: Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis, Scientific Reports, February 2016, Nature,
DOI: 10.1038/srep21807.
You can read the full text:

Read

Contributors

The following have contributed to this page